Table 5.
The GLMM analysis between the clinical characteristics of patients with PCa and the predictors is shown in Table 3.
Clinical Variable | Gene | Predictors | Estimate | Std. Error | t Value | Pr(>|t|) |
---|---|---|---|---|---|---|
GS | IL2RA | rs7093069 | 0.5864 | 0.2866 | 2.046 | 0.0472 * |
TNFRSF1B | rs2275416 | 0.7624 | 0.3618 | 2.107 | 0.0413 * | |
PSA | SLC11A1 | rs17221959 | 32.799 | 11.915 | 2.753 | 0.00869 ** |
TNFRSF1B | rs636964 | −33.887 | 12.208 | −2.776 | 0.00819 ** | |
rs2275416 | 23.014 | 7.629 | 3.017 | 0.00433 ** |
Abbreviations: GS, Gleason score; PSA, prostate-specific antigen. Significance codes: 0.001 < ‘**’ < 0.01 < ‘*’ < 0.05.